Duration of immunity in healthy adult volunteers who completed study 6108A1-500

Trial Profile

Duration of immunity in healthy adult volunteers who completed study 6108A1-500

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Sep 2009

At a glance

  • Drugs PF 5212366 (Primary) ; Hepatitis A-hepatitis B vaccine
  • Indications Meningococcal group B infections
  • Focus Pharmacodynamics
  • Sponsors Wyeth
  • Most Recent Events

    • 18 Sep 2009 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
    • 18 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Jan 2008 The expected completion date for this trial is now 1 Jan 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top